⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2884675 | 0.86 | — | — | |
| Butadiene SCHEMBL645108 | 0.68 | — | — | |
| Butadiene SCHEMBL776313 | 0.57 | — | — | |
| SCHEMBL3931 | 0.57 | — | — | |
| SCHEMBL974976 | 0.54 | — | — | |
| Acrolein SCHEMBL969406 | 0.54 | — | — | |
| Butadiene SCHEMBL43684 | 0.51 | — | — | |
| Butadiene SCHEMBL28451 | 0.51 | — | — | |
| Butadiene SCHEMBL2933701 | 0.51 | — | — | |
| SCHEMBL192 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8574544-B1 | Pharmaceutical composition of nanoparticles | GP MEDICAL, INC. (US) | 2013-11-05 | — | — | US | claimed |
| US-8535640-B1 | Pharmaceutical composition of nanoparticles | GP MEDICAL, INC. (US) | 2013-09-17 | — | — | US | claimed |
| US-8383082-B1 | Pharmaceutical composition of nanoparticles | GP MEDICAL, INC. (US) | 2013-02-26 | — | — | US | claimed |
| US-8361439-B1 | Pharmaceutical composition of nanoparticles | GP MEDICAL, INC. (US) | 2013-01-29 | — | — | US | claimed |
| US-8349799-B1 | Pharmaceutical composition of nanoparticles | GP MEDICAL, INC. (US) | 2013-01-08 | — | — | US | claimed |
| US-8119102-B1 | Pharmaceutical composition of nanoparticles | GP MEDICAL, INC. (US) | 2012-02-21 | — | — | US | claimed |
| US-7901711-B1 | Nanoparticles for protein/peptide delivery and delivery means thereof | GP MEDICAL, INC. (US) | 2011-03-08 | — | — | US | claimed |
| US-9885070-B2 | Process of preparing functionalized polymers via enzymatic catalysis | THE UNIVERSITY OF AKRON (US) | 2018-02-06 | — | — | US | disclosed |
| US-9259662-B2 | Photovoltaic panel-interfaced solar-greenhouse distillation systems | LEE JAMES WEIFU (US) | 2016-02-16 | — | — | US | disclosed |
| US-9139739-B2 | Method for preparing micro-patterned superhydrophobic/superhydrophilic coatings | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2015-09-22 | — | — | US | disclosed |
| US-9018423-B2 | Production of alpha, omega-diols | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-04-28 | — | — | US | disclosed |
| US-8969731-B2 | Patterned transparent conductors and related manufacturing methods | INNOVA DYNAMICS, INC. (US) | 2015-03-03 | — | — | US | disclosed |
| US-8846985-B2 | Production of alpha, omega-diols | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-09-30 | — | — | US | disclosed |
| US-4093618-A | STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
| US-4075161-A | STABILIZERS FOR POLYOLEFINS | CIBA-GEIGY CORPORATION (US) | 1978-02-21 | — | — | US | disclosed |
| US-4049713-A | STABILIZERS FOR POLYOLEFINS | CIBA-GEIGY CORPORATION (US) | 1977-09-20 | — | — | US | disclosed |
| US-4017514-A | Hypolipidemic agents | RICHARDSON-MERRELL INC. (US) | 1977-04-12 | — | — | US | disclosed |
| US-4011333-A | SUBSTITUTED THIOPHENECARBOXYLIC ACID AND ESTERS AS HYPOLIPIDEMIC AGENTS | RICHARDSON-MERRELL INC. (US) | 1977-03-08 | — | — | US | disclosed |
| US-3988363-A | STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1976-10-26 | — | — | US | disclosed |
| US-3984460-A | LIGHT AND HEAT STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1976-10-05 | — | — | US | disclosed |